1995年1月至2005年12月我们应用自体造血干细胞联合 HLA 半相合异基因骨髓移植治疗33例恶性血液病。33例患者中,自体骨髓联合 HLA 半相合异基因骨髓移植(简称 BM 加 BM 组)21例,自体外周血干细胞联合 HIA 半相合异基因骨髓移植(简称 PB 加 BM 组)12例。BM 加 BM组中,男15例,女6例,年龄16～50岁,中位年龄25岁;原 From January 1995 to December 2005, we used autologous hematopoietic stem cells combined with HLA haploidentical allogeneic bone marrow transplantation in the treatment of 33 cases of hematologic malignancies. Among the 33 patients, 21 patients were treated with autologous bone marrow combined with HLA haploidentical allogeneic bone marrow transplantation (BM plus BM group) and 12 with autologous peripheral blood stem cells combined with HIA haploidentical allogeneic bone marrow transplantation (PB plus BM group). BM plus BM group, 15 males and 6 females, aged 16 to 50 years, the median age of 25 years of age;